Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.54 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | MGLL | Q99685 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | COMT | P21964 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acitazanolast SCHEMBL3116621 | 0.99 | GPR35 (0.53) | GPR35PTPN11PTPN1MGLLMAPT | |
| SCHEMBL9314587 | 0.89 | MGLL (0.45) | MGLLMAPTMMP2MMP9COMT | |
| SCHEMBL22167182 | 0.87 | MGLL (0.54) | MGLLMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL6694019 | 0.84 | MAPT (0.59) | MAPTSMN1; SMN2NPC1RAB9ATSHR | |
| SCHEMBL9573406 | 0.84 | MAPT (0.43) | MGLLMAPTMMP2MMP9COMT | |
| SCHEMBL31680549 | 0.82 | MMP2 (0.54) | MAPTMMP2MMP9COMTMMP8 | |
| SCHEMBL950001 | 0.81 | CYP3A4 (0.60) | MAPTSMN1; SMN2NPC1RAB9AKDM4E | |
| SCHEMBL4532779 | 0.79 | KDM4E (0.53) | MGLLMAPTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL23796628 | 0.79 | LMNA (0.41) | MAPTMMP2MMP9COMTMMP8 | |
| Tazanolast SCHEMBL28495 | 0.79 | HPGD (0.45) | MAPTSMN1; SMN2NPC1RAB9ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 630 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250009940-A1 | ANTIMICROBIAL WRAPS FOR MEDICAL IMPLANTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-01-09 | — | — | US | claimed |
| EP-4433107-A1 | ANTIMICROBIAL WRAPS FOR MEDICAL IMPLANTS | Board of Regents, The University of Texas System (US) | 2024-09-25 | — | — | EP | claimed |
| US-20240033124-A1 | DRUG DELIVERY CONTACT LENS AND OPHTHALMIC PHARMACEUTICAL COMPOSITION | DAE WON PHARMACEUTICAL CO., LTD (KR) | 2024-02-01 | — | — | US | claimed |
| EP-4275675-A1 | DRUG DELIVERY CONTACT LENS AND OPHTHALMIC PHARMACEUTICAL COMPOSITION | Dae Won Pharmaceutical Co., Ltd. (KR) | 2023-11-15 | — | — | EP | claimed |
| WO-2023091998-A1 | ANTIMICROBIAL WRAPS FOR MEDICAL IMPLANTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-05-25 | — | — | WO | claimed |
| WO-2023069028-A1 | A PROCESS FOR THE PREPARATION OF DRY POWDER COMPOSITIONS FOR INHALATION | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi (TR) | 2023-04-27 | — | — | WO | claimed |
| WO-2022149914-A1 | DRUG DELIVERY CONTACT LENS AND OPHTHALMIC PHARMACEUTICAL COMPOSITION | 대원제약 주식회사 | 2022-07-14 | — | — | WO | claimed |
| US-20210178023-A1 | ANTIMICROBIAL WRAPS FOR MEDICAL IMPLANTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-06-17 | — | — | US | claimed |
| EP-2913062-B1 | THERAPEUTIC OR PROPHYLACTIC AGENT FOR RETINOPATHY OF PREMATURITY AND METHOD OF TESTING FOR RETINOPATHY OF PREMATURITY | JAPAN INNOVATIVE THERAPEUTICS INC (JP) | 2019-05-08 | — | — | EP | claimed |
| CN-109718376-A | It releives the ophthalmically acceptable product of effect with antiallergic | 晶硕光学股份有限公司 | 2019-05-07 | — | — | CN | claimed |
| US-20030162828-A1 | Use of leukotriene receptor antagonist for treatment of scarring | SCHLESINGER FAMILY PARTNERS, A HAWAII LIMITED PARTNERSHIP | 2003-08-28 | — | — | US | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| WO-2003024488-A2 | COMBINATION OF A PDE INHIBITOR AND A LEUKOTRIENE RECEPTOR ANTAGONIST | ALTANA PHARMA AG (DE) | 2003-03-27 | — | — | WO | claimed |
| US-6224907-B1 | Anti-asthma therapy | ALZA CORPORATION | 2001-05-01 | — | — | US | claimed |
| EP-0694310-B1 | REVERSIBLE, THERMALLY GELLING WATER-BASE MEDICINAL COMPOSITION | WAKAMOTO PHARMA CO LTD (JP) | 2000-02-16 | — | — | EP | claimed |
| CN-1048393-C | Aqueous drug composition having property of reversible thermosetting gelation | WAKAMOTO PHARMA CO LTD (JP) | 2000-01-19 | — | — | CN | claimed |
| US-5693337-A | OIL IN WATER EMULSION CONTAINING DRUG, LECITHIN, CITRIC ACID, AND METHIONINE, PHENYLALANINE, SERINE, AND/OR HISTIDINE; SYNERGISTIC, STORAGE STABILITY | WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) | 1997-12-02 | — | — | US | claimed |
| EP-0700678-A1 | Stable lipid emulsion | Wakamoto Pharmaceutical Co., Ltd. (JP) | 1996-03-13 | — | — | EP | claimed |
| EP-0481118-B1 | A method for producing butyl 3'-(1H-tetrazol-5-yl) oxanilate | WAKAMOTO PHARMA CO LTD (JP) | 1995-08-02 | — | — | EP | claimed |
| CN-1097593-A | Aqueous drug composition having property of reversible thermosetting gelation | WAKAMOTO PHARMA CO LTD (JP) | 1995-01-25 | — | — | CN | claimed |